Novel mechanisms of sympatho-excitation in chronic heart failure

Irving H Zucker1, Rainer U Pliquett

  • 1Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, NE 68198-4575, USA.

Heart Failure Monitor
|March 14, 2003
PubMed

Insights

Chronic heart failure (CHF) involves harmful neurohormonal and reflex changes that increase sympathetic nerve activity. Exercise training can improve these factors, offering potential new therapeutic strategies for heart failure.

Area of Science:

  • Cardiovascular Physiology
  • Neuroendocrinology

Background:

  • Chronic heart failure (CHF) elevates regulatory hormones, initially beneficial but later detrimental.
  • Neurohumoral excitation in CHF results from abnormal inhibitory reflexes (baroreflex, cardiopulmonary) and enhanced sympatho-excitatory reflexes (chemoreflex, cardiac sympathetic afferent).

Purpose of the Study:

  • To review the neurohormonal and reflex regulation of sympathetic outflow in chronic heart failure.
  • To explore the role of hormones like angiotensin II (Ang II) and nitric oxide (NO) in modulating sympathetic activity.
  • To examine the impact of exercise training on these regulatory mechanisms.

Main Methods:

  • Review of existing literature on neurohormonal and reflex pathways in CHF.
  • Analysis of experimental animal data on the interplay between Ang II and NO.
  • Examination of exercise training effects on sympathetic activity and reflex function.

Main Results:

  • CHF is characterized by increased sympathetic outflow due to altered cardiovascular reflexes and elevated hormones (Ang II, NO, endothelin-1).
  • A reciprocal relationship between Ang II and NO in modulating sympathetic outflow is suggested by animal data.
  • Exercise training reduces sympathetic nerve activity, lowers plasma Ang II, and improves baroreflex function in CHF.

Conclusions:

  • Abnormal reflex regulation in CHF can predict poor outcomes.
  • Understanding these neurohormonal and reflex mechanisms is crucial for developing novel treatments for chronic heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...